Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]
Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]
Dignam joined Chemours in 2015. She has held senior roles in the chemical industry in business and operations, sales and marketing, commercialization, and supply chain.